Paper178485
Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine.
Parkhurst JR and 2 others. Chemotherapy, 1976. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine. Papers, record 178485. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/178485
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HeLa Cells | Major topic |
| Thymidine | Major topic |
| Trifluridine | Major topic |
| Vaccinia virus | Major topic |
| Virus Replication | Major topic |
| Animals | |
| Carcinoma, Hepatocellular | |
| Cell Division | |
| Cell Line | |
| Depression, Chemical | |
| Leukemia, Experimental | |
| Liver Neoplasms | |
| Mice |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36862595 | Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023. | MMWR Morb Mortal Wkly Rep | 2023 | https://conductscience.org/library/papers/36862595 | PubMed |
| 25400294 | Synthesis and anticancer activity evaluation of 3,4-mono- and bicyclosubstituted N-(het)aryl trifluoromethyl succinimides. | J Fluor Chem | 2014 | https://conductscience.org/library/papers/25400294 | PubMed |
| 21278209 | Evaluation of therapeutic interventions for vaccinia virus keratitis. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21278209 | PubMed |
| 6403411 | Corneal epithelial dysplasia after trifluridine use. | Graefes Arch Clin Exp Ophthalmol | 1983 | https://conductscience.org/library/papers/6403411 | PubMed |
| 6299179 | Inhibition of human cytomegalovirus by trifluorothymidine. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6299179 | PubMed |
| 6284470 | Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections. | Drugs | 1982 | https://conductscience.org/library/papers/6284470 | PubMed |
| 6271050 | Inhibition of mouse LM cell replication by trifluorothymidine: role of cytosolic deoxythymidine kinase. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6271050 | PubMed |
| 213016 | HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/213016 | PubMed |
| 192143 | Experimental herpes simplex virus type 1 encephalitis: treatment with 5-trifluoromethyl-2'-deoxyuridine. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/192143 | PubMed |
| 28691 | Biological effects of 5-carboxy-2'-deoxyuridine: hydrolysis product of 5-trifluoromethyl-2'-deoxyuridine. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/28691 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/178485
GET https://conductscience.org/api/papers/v1/178485/authors